Announcement
20 May 2020
In June 2020, the German authorities extended the scope of its investment screening to include certain pharmaceutical goods including medicine, medical products and personal protective equipment. The scope was extended following the outbreak of COVID-19.
Source
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
Implementation date
03 Jun 2020
Revocation date:
No revocation date
See all
This Thread tracks harmful trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
70729
194
This Thread tracks harmful trade policy interventions affecting HS codes for medical consumables, equipment, medicines, vaccines, as well as chemicals used in pharmaceutical production. It covers all types of interventions monitored by Global Trade Alert since 2009. To identify relevant policy actions, the Global Trade Alert team focused on the identification of relevant HS codes following the pr...
Published: 09 Jan 2025
7352
152
This Thread tracks harmful trade policy interventions introduced by G7 members since 2009. It covers all types of interventions monitored by Global Trade Alert.
Published: 13 Jan 2025
25553
38
This Thread tracks harmful trade policy interventions introduced by G20 members since 2009. It covers all types of interventions monitored by Global Trade Alert.
Published: 15 Jan 2025
54047
121
This Thread documents policy interventions affecting foreign direct investments (FDI) since 2017. Specifically, it encompasses screening mechanisms, foreign ownership limitations and other policies affecting international investors’ operations.
Published: 31 Jan 2025
940
87